NO911041L - Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika. - Google Patents

Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.

Info

Publication number
NO911041L
NO911041L NO91911041A NO911041A NO911041L NO 911041 L NO911041 L NO 911041L NO 91911041 A NO91911041 A NO 91911041A NO 911041 A NO911041 A NO 911041A NO 911041 L NO911041 L NO 911041L
Authority
NO
Norway
Prior art keywords
preparation
tetrazolyltyomethyl
procedure
cephalosporin antibiotics
cephalosporin
Prior art date
Application number
NO91911041A
Other languages
English (en)
Norwegian (no)
Other versions
NO911041D0 (no
Inventor
Frederick Henri Jung
Original Assignee
Ici Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Pharma filed Critical Ici Pharma
Publication of NO911041D0 publication Critical patent/NO911041D0/no
Publication of NO911041L publication Critical patent/NO911041L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NO91911041A 1990-03-16 1991-03-15 Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika. NO911041L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90400724 1990-03-16

Publications (2)

Publication Number Publication Date
NO911041D0 NO911041D0 (no) 1991-03-15
NO911041L true NO911041L (no) 1991-09-17

Family

ID=8205690

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911041A NO911041L (no) 1990-03-16 1991-03-15 Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.

Country Status (16)

Country Link
US (1) US5200404A (pt)
EP (1) EP0447118B1 (pt)
JP (1) JPH05247058A (pt)
KR (1) KR910016762A (pt)
AT (1) ATE131484T1 (pt)
AU (1) AU638556B2 (pt)
CA (1) CA2038411A1 (pt)
DE (1) DE69115313T2 (pt)
FI (1) FI911286A7 (pt)
GB (1) GB9104238D0 (pt)
IE (1) IE910711A1 (pt)
IL (1) IL97439A0 (pt)
NO (1) NO911041L (pt)
NZ (1) NZ237351A (pt)
PT (1) PT97044A (pt)
ZA (1) ZA911657B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544166A3 (en) * 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives
JPH11124384A (ja) * 1997-10-17 1999-05-11 Otsuka Chem Co Ltd 3−セフェム化合物の製造法
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
KR20100065191A (ko) 2007-09-14 2010-06-15 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 1,3-이치환된 4-(아릴-x-페닐)-1h-피리딘-2-온
CA2696948C (en) 2007-09-14 2013-04-30 Jose Maria Cid-Nunez 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
CA2735764C (en) 2008-09-02 2016-06-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
BRPI0921333A2 (pt) 2008-11-28 2015-12-29 Addex Pharmaceuticals Sa derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
NZ596078A (en) 2009-05-12 2013-06-28 Janssen Pharmaceuticals Inc 1,2,4-TRIAZOLO [4,3-a] PYRIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
EA020671B1 (ru) 2009-05-12 2014-12-30 Янссен Фармасьютикалз, Инк. ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
EP2643320B1 (en) 2010-11-08 2015-03-04 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
CA2815002C (en) 2010-11-08 2019-10-22 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
LT3431106T (lt) 2014-01-21 2021-02-10 Janssen Pharmaceutica Nv Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
KR102414246B1 (ko) 2014-01-21 2022-06-27 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024134A (en) * 1971-01-29 1977-05-17 Glaxo Laboratories Limited Syn isomers of cephalosporins having α-hydroximino- or α-acyloxyiminoacylamido groups at position-7
GB1433141A (en) * 1972-07-07 1976-04-22 Glaxo Lab Ltd Antibiotics
US3926957A (en) * 1971-01-29 1975-12-16 Glaxo Lab Ltd Penicillin antibiotics
US3991046A (en) * 1972-07-07 1976-11-09 Glaxo Laboratories Limited Penicillin antibiotics
US4493833A (en) * 1976-04-12 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
AU536842B2 (en) * 1978-12-29 1984-05-24 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin antibiotics
EP0272827A3 (en) * 1986-12-23 1990-02-07 ZENECA Pharma S.A. 3-heterocyclicthiomethyl cephalosphorins

Also Published As

Publication number Publication date
FI911286L (fi) 1991-09-17
IL97439A0 (en) 1992-06-21
FI911286A7 (fi) 1991-09-17
PT97044A (pt) 1991-10-31
ATE131484T1 (de) 1995-12-15
GB9104238D0 (en) 1991-04-17
IE910711A1 (en) 1991-09-25
AU7263991A (en) 1991-09-19
US5200404A (en) 1993-04-06
NO911041D0 (no) 1991-03-15
FI911286A0 (fi) 1991-03-15
CA2038411A1 (en) 1991-09-17
EP0447118A2 (en) 1991-09-18
ZA911657B (en) 1991-11-27
JPH05247058A (ja) 1993-09-24
AU638556B2 (en) 1993-07-01
KR910016762A (ko) 1991-11-05
EP0447118B1 (en) 1995-12-13
EP0447118A3 (en) 1992-06-03
DE69115313D1 (de) 1996-01-25
DE69115313T2 (de) 1996-05-02
NZ237351A (en) 1992-12-23

Similar Documents

Publication Publication Date Title
NO996108L (no) 9-oksinerytromycinderivater
NO911041D0 (no) Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
AU614204B2 (en) 16-hydroxymethyl amphotericin b derivatives
EP0453574A4 (en) Cephalosporin derivative
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
CA2120229A1 (fr) Derives de methylpiperazinoazepine, leur preparation et leur utilisation
IE893578L (en) Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics
CA2179634A1 (en) 4-arylisoindole analgesics
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
NO890287L (no) Fremstilling av beta-laktam-antibiotika.
WO1987003590A1 (fr) Medicament pour le traitement des maladies du foie
GR3004095T3 (pt)
GB9323404D0 (en) Pharmaceuticals
WO1996027378A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB9323403D0 (en) Pharmaceuticals
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
JO1229B1 (en) Penicillin derivatives
AU5932394A (en) New compound, leustroducsin H, its preparation and its therapeutic use
GR3020519T3 (en) Polar cephalosporin derivatives and process for their preparation